- Home
- ZCAR vs APVO Comparison
ZCAR vs APVO Comparison
Compare ZCAR & APVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZCAR
- APVO
- Stock Information
- Founded
- ZCAR 2013
- APVO 2016
- Country
- ZCAR India
- APVO United States
- Employees
- ZCAR N/A
- APVO N/A
- Industry
- ZCAR Blank Checks
- APVO Biotechnology: Pharmaceutical Preparations
- Sector
- ZCAR Finance
- APVO Health Care
- Exchange
- ZCAR Nasdaq
- APVO Nasdaq
- Market Cap
- ZCAR 3.8M
- APVO 4.4M
- IPO Year
- ZCAR N/A
- APVO N/A
- Fundamental
- Price
- ZCAR $1.46
- APVO $4.77
- Analyst Decision
- ZCAR
- APVO Strong Buy
- Analyst Count
- ZCAR 0
- APVO 1
- Target Price
- ZCAR N/A
- APVO $296.00
- AVG Volume (30 Days)
- ZCAR 283.3K
- APVO 485.4K
- Earning Date
- ZCAR 02-12-2025
- APVO 11-07-2024
- Dividend Yield
- ZCAR N/A
- APVO N/A
- EPS Growth
- ZCAR N/A
- APVO N/A
- EPS
- ZCAR 1.91
- APVO N/A
- Revenue
- ZCAR $9,089,489.00
- APVO N/A
- Revenue This Year
- ZCAR N/A
- APVO N/A
- Revenue Next Year
- ZCAR N/A
- APVO N/A
- P/E Ratio
- ZCAR $0.91
- APVO N/A
- Revenue Growth
- ZCAR N/A
- APVO N/A
- 52 Week Low
- ZCAR $1.30
- APVO $3.65
- 52 Week High
- ZCAR $1,289.00
- APVO $399.60
- Technical
- Relative Strength Index (RSI)
- ZCAR 24.09
- APVO 35.34
- Support Level
- ZCAR $4.75
- APVO $3.65
- Resistance Level
- ZCAR $5.71
- APVO $4.78
- Average True Range (ATR)
- ZCAR 0.55
- APVO 1.95
- MACD
- ZCAR -0.31
- APVO -0.70
- Stochastic Oscillator
- ZCAR 0.90
- APVO 7.55
About ZCAR Zoomcar Holdings Inc.
Zoomcar Holdings Inc is India's largest marketplace for cars on rent. Zoomcar is a leading emerging-market-focused peer-to-peer car-sharing marketplace, with approximately 21,000 vehicles registered through its platform. The Company derives its revenue principally from short-term self-drive rentals and vehicle subscriptions. The self-drive rental business generates the majority of revenue. Geographically The company operates in India, Egypt, Indonesia, Vietnam, and the Philippines, Out of which the majority of revenue is derived from India.
About APVO Aptevo Therapeutics Inc.
Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed using ADAPTIR modular protein technology platform. The versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.